New clinical trials surrounding this compound, specifically the high-dose formulation ZPHC ZPHC, indicate a impressive benefit on weight loss and associated chronic illnesses . Scientists posit that this combined compound, targeting both GLP-1 and GIP systems, may represent a noteworthy advance in the management of excess weight and related metabo